Vir Biotechnology, Inc. · NASDAQ:VIR
BlackRock, Inc. reported a 10.80% stake in Vir Biotechnology, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 28, 2025
BlackRock, Inc. reported a 10.80% stake in Vir Biotechnology, Inc., 14,826,039 shares, as a passive investor on Mar 31, 2025. Filed Apr 28, 2025 (Schedule 13G/A).
- Stake
- 10.80%
- Shares
- 14,826,039
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 10.80% | 14,826,039 |
Source
Related
- Vir Biotechnology, Inc.
- BlackRock, Inc.
- Vir Biotechnology, Inc. shareholders
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026